Panel Discussion – What Do We Need To Do To Get Protein Degraders To Clinic For Treating Neurodegenerative Disease?
Time: 10:00 am
day: Conference Day One
Details:
- How translatable are the current models to clinic and what do we need to advance them for approved use?
- What are the regulatory hurdles for protein degraders in neurodegenerative disease?
- What lessons have been learnt by past failures in neurodegenerative drug development that can inform the success of protein degraders?
